Covered recipient · General Payments record
PETER B RINTELS
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2018–2024
$3,306.61
- Reported across 173 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $357.75 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $80.34 | 3 |
| Rigel Pharmaceuticals, Inc. | $58.32 | 1 |
| EISAI INC. | $55.11 | 2 |
| GlaxoSmithKline, LLC. | $49.37 | 2 |
| TAIHO ONCOLOGY, INC. | $47.96 | 2 |
| Dendreon Pharmaceuticals LLC | $25.50 | 1 |
| Acerta Pharma LLC | $20.94 | 1 |
| PFIZER INC. | $20.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.86 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105951169 | CMS |
| ABBVIE INC. | $20.91 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105951171 | CMS |
| ABBVIE INC. | $34.57 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105951173 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.94 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104255047 | CMS |
| Dendreon Pharmaceuticals LLC | $25.50 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149322989 | CMS |
| Eisai Inc. | $23.74 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110773017 | CMS |
| Eisai Inc. | $31.37 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110773015 | CMS |
| GlaxoSmithKline, LLC. | $22.47 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116296759 | CMS |
| GlaxoSmithKline, LLC. | $26.90 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116285116 | CMS |
| PFIZER INC. | $20.21 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131387869 | CMS |
| Rigel Pharmaceuticals, Inc. | $58.32 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145209083 | CMS |
| TAIHO ONCOLOGY, INC. | $21.41 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137942228 | CMS |
| TAIHO ONCOLOGY, INC. | $26.55 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137942230 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.